Discovery of a Cushing's syndrome protein kinase A mutant that biases signaling through type I AKAPs.

Omar, Mitchell H; Byrne, Dominic P; Shrestha, Safal; Lakey, Tyler M; Lee, Kyung-Soon; Lauer, Sophia M; Collins, Kerrie B; Daly, Leonard A et al. · Sci Adv · 2024

basic_science · Level V

Where this comes from

Abstract

Adrenal Cushing's syndrome is a disease of cortisol hypersecretion often caused by mutations in protein kinase A catalytic subunit (PKAc). Using a personalized medicine screening platform, we discovered a Cushing's driver mutation, PKAc-W196G, in ~20% of patient samples analyzed. Proximity proteomics and photokinetic imaging reveal that PKAc<sup>W196G</sup> is unexpectedly distinct from other described Cushing's variants, exhibiting retained association with type I regulatory subunits (RI) and their corresponding A kinase anchoring proteins (AKAPs). Molecular dynamics simulations predict that substitution of tryptophan-196 with glycine creates a 653-cubic angstrom cleft between the catalytic core of PKAc<sup>W196G</sup> and type II regulatory subunits (RII), but only a 395-cubic angstrom cleft with RI. Endocrine measurements show that overexpression of RIα or redistribution of PKAc<sup>W196G</sup> via AKAP recruitment counteracts stress hormone overproduction. We conclude that a W196G mutation in the kinase catalytic core skews R subunit selectivity and biases AKAP association to drive Cushing's syndrome.

Medical subject headings